## Answer
(model generated chain of thought explanation)

To approach this question, let's consider the patient's symptoms and medical history step by step.

1. **Decreased appetite**: This symptom can be related to various physiological or pathological conditions. Given that the patient is 42 years old and has a stable BMI, we need to think about other factors that could contribute to decreased appetite.

2. **Previous stable BMI of 24 kg/m^2**: This suggests that any changes in appetite are likely due to an underlying condition rather than a temporary change in body composition or metabolism.

3. **Decreased appetite over the past month**: This duration is significant and warrants consideration of chronic conditions, lifestyle factors, or hormonal imbalances.

4. **Considering the options**:
   - A. Decreased hypothalamic neuropeptide Y (NPY): NPY is a neurotransmitter involved in regulating appetite. However, decreased NPY would typically lead to increased appetite, not decreased.
   - B. Potentiation of cholecystokinin (CCK): CCK is a hormone that stimulates digestion and satiety. An increase in CCK could potentially lead to an increase in appetite, which contradicts the patient's reported decrease.
   - C. Increased fatty acid oxidation: This process is crucial for energy production but does not directly explain decreased appetite.
   - D. Inhibition of proopiomelanocortin neurons (POMC): POMC is a precursor to several hormones, including adrenocorticotropic hormone (ACTH), melanocyte-stimulating hormone (MSH), and beta-endorphin. The inhibition of POMC would lead to decreased production of these hormones, which in turn could decrease appetite.

Given the above considerations, the most plausible explanation for the patient's decreased appetite is the inhibition of proopiomelanocortin neurons, leading to a decrease in the production of several anorexigenic (appetite-suppressing) hormones. This aligns with option D.

The final answer is: $\boxed{D}$